Innovative Medical Management Co.,Ltd. (SHE:002173)
China · Delayed Price · Currency is CNY 17.28
-0.44 (-2.48%)
Sep 11, 2026, 3:04 PM CST
SHE:002173 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
| 7,579 | 9,492 | 3,513 | 3,857 | 2,903 | 3,723 | |
Market Cap Growth | -25.07% | 170.23% | -8.92% | 32.83% | -22.01% | 45.12% |
Enterprise Value | 7,237 | 9,135 | 3,032 | 3,300 | 2,321 | 2,942 |
Last Close Price | 17.28 | 21.51 | 7.96 | 8.74 | 6.52 | 8.35 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Forward PE | - | 128.39 | 128.39 | 128.39 | 128.39 | 128.39 |
PS Ratio | 10.56 | 12.15 | 4.31 | 4.79 | 4.09 | 5.23 |
PB Ratio | 4.56 | 5.38 | 1.98 | 2.06 | 1.52 | 1.88 |
P/TBV Ratio | 5.16 | 6.07 | 2.13 | 2.22 | 1.63 | 2.01 |
P/OCF Ratio | - | 125.01 | - | 349.64 | - | 85.84 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 10.09 | 11.69 | 3.72 | 4.10 | 3.27 | 4.14 |
EV/EBITDA Ratio | - | 566.05 | 110.77 | 58.03 | 264.76 | 95.18 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.07 | 0.05 | 0.04 | 0.04 | 0.03 | 0.03 |
Debt / EBITDA Ratio | - | 3.26 | 2.06 | 1.02 | 2.97 | 2.19 |
Net Debt / Equity Ratio | -0.21 | -0.19 | -0.20 | -0.28 | -0.31 | -0.37 |
Net Debt / EBITDA Ratio | 11.74 | -20.41 | -12.77 | -9.05 | -68.24 | -23.67 |
Net Debt / FCF Ratio | 6.10 | 38.34 | 6.44 | 6.04 | 4.05 | 10.87 |
Asset Turnover | 0.34 | 0.36 | 0.36 | 0.35 | 0.29 | 0.27 |
Inventory Turnover | 22.87 | 18.57 | 17.96 | 15.68 | 14.72 | 17.13 |
Quick Ratio | 1.74 | 1.71 | 1.72 | 2.12 | 2.22 | 2.57 |
Current Ratio | 1.85 | 1.84 | 1.86 | 2.25 | 2.39 | 2.72 |
Return on Equity (ROE) | -4.65% | -2.05% | -5.15% | -1.82% | -3.79% | -5.01% |
Return on Assets (ROA) | -3.38% | -1.91% | -1.81% | -1.07% | -2.30% | -2.03% |
Return on Invested Capital (ROIC) | -8.32% | -4.67% | -4.66% | -2.96% | -7.05% | -6.89% |
Return on Capital Employed (ROCE) | -6.50% | -3.60% | -3.40% | -2.00% | -4.50% | -3.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Earnings Yield | -1.01% | -0.37% | -2.67% | -0.89% | -2.53% | -2.78% |
FCF Yield | -0.76% | -0.09% | -1.55% | -2.21% | -5.08% | -1.81% |
Buyback Yield / Dilution | -6.89% | 2.62% | -4.39% | 3.77% | 0.99% | 1.31% |
Total Shareholder Return | -6.89% | 2.62% | -4.39% | 3.77% | 0.99% | 1.31% |